Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 63 positions · Total reported value $1.89B · Top-10 concentration 50.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, Logos Global Management LP disclosed 63 equity positions with a combined reported value of $1.89B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 50.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were RVMD ($194.50M), ERAS ($180.41M), IDYA ($114.95M). By sector, the heaviest allocations are Health Care 93.6%, Other 6.4%. Versus the prior quarter, allocation shifted toward Health Care (+7.3pp) and away from Other (-7.3pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q1 2026 were UTHR ($47.44M), MDGL ($44.49M), XENE ($26.17M).

Of the 20 positions fully exited versus the prior quarter, the largest were CDTX ($68.48M), RNAM ($36.06M), JAZZ ($34.00M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • UTHR UNITED THERAPEUTICS CORP DEL · $47.44M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $44.49M
  • XENE XENON PHARMACEUTICALS INC · $26.17M
  • ALKS ALKERMES PLC · $12.38M
  • TENX TENAX THERAPEUTICS INC · $9.99M
  • AVBP ARRIVENT BIOPHARMA INC COM · $8.07M
  • RLAY RELAY THERAPEUTICS INC COM · $7.46M
  • MGTX MEIRAGTX HLDGS PLC COM · $6.06M

Fully Exited (vs previous quarter)

  • CDTX CIDARA THERAPEUTICS INC · prev qtr: $68.48M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $36.06M
  • JAZZ JAZZ PHARMACEUTICALS PLC · prev qtr: $34.00M
  • APLS APELLIS PHARMACEUTICALS INC · prev qtr: $25.12M
  • QURE UNIQURE NV · prev qtr: $16.15M
  • KNSA KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A · prev qtr: $14.44M
  • KYMR KYMERA THERAPEUTICS INC · prev qtr: $10.12M
  • NRIX NURIX THERAPEUTICS INC · prev qtr: $9.48M

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 93.6%
Other 6.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.00M $194.50M 10.30%
10.30%
Add
2 11.15M $180.41M 9.56%
9.56%
Reduce
3 3.45M $114.95M 6.09%
6.09%
Add
4 285.00K $91.82M 4.86%
4.86%
Reduce
5 2.12M $84.41M 4.47%
4.47%
Add
6 675.00K $75.16M 3.98%
3.98%
Add
7 3.00M $62.76M 3.33%
3.33%
Reduce
8 875.00K $57.67M 3.06%
3.06%
Add
9 3.21M $47.84M 2.53%
2.53%
Hold
10 80.00K $47.44M 2.51%
2.51%
New
11 1.50M $45.23M 2.40%
2.40%
Add
12 85.00K $44.49M 2.36%
2.36%
New
13 450.00K $39.14M 2.07%
2.07%
Add
14 575.00K $38.92M 2.06%
2.06%
Add
15 1.24M $36.86M 1.95%
1.95%
Add
16 200.00K $36.67M 1.94%
1.94%
Hold
17 560.00K $35.81M 1.90%
1.90%
Add
18 400.00K $33.57M 1.78%
1.78%
Add
19 3.85M $32.61M 1.73%
1.73%
Add
20 850.00K $32.55M 1.73%
1.73%
Add
21 2.40M $28.63M 1.52%
1.52%
Add
22 1.50M $27.96M 1.48%
1.48%
Reduce
23 1.07M $26.70M 1.42%
1.42%
Reduce
24 500.00K $26.36M 1.40%
1.40%
Reduce
25 450.00K $26.17M 1.39%
1.39%
New
26 1.20M $25.92M 1.37%
1.37%
Add
27 1.40M $25.38M 1.34%
1.34%
Add
28 500.00K $24.10M 1.28%
1.28%
Reduce
29 915.00K $22.56M 1.20%
1.20%
Reduce
30 1.95M $20.75M 1.10%
1.10%
Reduce
31 500.00K $19.60M 1.04%
1.04%
Add
32 3.21M $19.37M 1.03%
1.03%
Reduce
33 600.00K $19.21M 1.02%
1.02%
Add
34 200.00K $18.48M 0.98%
0.98%
Reduce
35 300.00K $17.43M 0.92%
0.92%
Reduce
36 750.00K $16.70M 0.88%
0.88%
Reduce
37 3.15M $16.66M 0.88%
0.88%
Add
38 450.00K $14.27M 0.76%
0.76%
Add
39 1.00M $13.90M 0.74%
0.74%
Hold
40 750.00K $13.38M 0.71%
0.71%
Add
41 350.00K $12.38M 0.66%
0.66%
New
42 950.00K $12.04M 0.64%
0.64%
Add
43 1.23M $11.16M 0.59%
0.59%
Add
44 625.00K $9.99M 0.53%
0.53%
New
45 700.00K $9.73M 0.52%
0.52%
Reduce
46 482.50K $8.86M 0.47%
0.47%
Reduce
47 250.00K $8.37M 0.44%
0.44%
Reduce
48 350.00K $8.07M 0.43%
0.43%
New
49 750.00K $7.46M 0.40%
0.40%
New
50 450.00K $6.58M 0.35%
0.35%
Reduce

FAQ

What did Logos Global Management LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Logos Global Management LP reported 63 equity positions worth $1.89B in aggregate; its largest disclosed positions were RVMD ($194.50M), ERAS ($180.41M), IDYA ($114.95M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $1.89B of long equity holdings across 63 positions as of 2026-Q1. Top-10 holdings account for 50.7% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →